ICH Proposes Harmonized Bioequivalence Standards For Solid Oral Drugs
Executive Summary
The first document of a three-part series of ICH guidelines on conducting bioequivalence studies for orally administered immediate-release solid oral dosage forms has been issued for stakeholder consultation.
You may also be interested in...
FDA-EMA Parallel Scientific Advice Program For Complex Generics Could Add Health Canada
Preliminary discussions are ongoing about adding Health Canada to the program intended to foster streamlined complex generic approval and increase access.
Generics Industry Welcomes Fresh ICH Harmonization Initiative
The International Council for Harmonisation has unveiled plans to develop and publish several new guidance documents, including one on bioequivalence for modified-release products, which has been welcomed by global off-patent industry body the IGBA.
Global Industry Hails Bioequivalence Progress
For the first time, a working group within the International Council for Harmonization has started work on a regulatory topic specifically tailored to the global generics and biosimilars industry.